30th Mar 2005 17:33
Alliance Pharma PLC30 March 2005 For immediate release: 30 March 2005 ALLIANCE PHARMA PLC ("Alliance" or "the Company") SHAREHOLDINGS IN COMPANY Fidelity acquire an additional 3,700,000 ordinary shares On 30th March 2005 the Company was notified by Fidelity Investments, ("FMR Corp"), that it had increased its shareholding by 3,700,000 shares. The notifiableinterest is with FMR Corp and Fidelity International Limited (FIL) which alsocomprises the notifiable interest of Mr Edward C Johnson 3d, a principalshareholder of FMR Corp and Fidelity International Limited. The shares heldcurrently are as follows: Shares Held Management Company Nominee/Registered Name 240,500 FIL Brown Brothers Harriman Ltd LUX 9,959,500 FMRCO Mellon Bank TOTAL 10,200,000 The total percentage shareholding of FMR Corp and Fidelity International Limitedis now 9.43% On 30th March 2005, the Company was also notified that F&C Asset Management hasceased to have a notifiable interest in the Company. - ends - For further information please contacts: Alliance Pharma plc John Dawson, CEO 01249 466966 Beattie Financial Mike Wort/John Moriarty 020 7398 3300 About Alliance Pharma Alliance Pharma, founded in 1996, is an AIM listed emerging specialitypharmaceutical company based in Chippenham, Wiltshire. The company has a strongtrack record of acquiring the rights to established niche brands and owns, orshares, the rights to 31 branded pharmaceutical products and is currentlyexploring several opportunities to expand the range. In November 2003 thecompany acquired Peerless Technology Group Plc constituting a reverse takeoverunder the AIM rules. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Alliance Pharma